Precision Medicine Conference London

Precision oncology buyers

A precision medicine conference London oncology teams use to pick data partners

ImmunoMark Summit is a precision medicine conference London oncology developers use to decide which sequencing, data and AI partners make it into their programmes.

Precision oncology does not sit in one stream at ImmunoMark. Comprehensive genomic profiling and companion diagnostics live in Stream 2, Biomarkers & Companion Diagnostics. Biomarker-driven trial design, safety and AI in drug discovery live in Stream 1, Next-Gen Immuno-Oncology. For a genomics or data vendor, that split is useful: your buyers are spread across translational, clinical development and data science teams, and both streams run side by side on 3–4 March 2027.

The prospectus lists Precision Medicine / Personalised Therapy, Bioinformatics / Data Science, Clinical Development and Translational Medicine among the key departments, and on the clinical side, Genomics / Precision Oncology Labs and Pathology / Molecular Diagnostics.

55–60%biotech and pharma

10–15%academic and research

5–10%clinicians

~5%government, regulatory and industry bodies

The 2027 speaker panel includes Matteo Cesaroni, Head of Biomarker Data Analytics at Sanofi, Qingli (Ramina) Guo, Senior Data Scientist at The Francis Crick Institute, and Amit Gupta, Founder and CEO of Akrivia Biomedics. Data people speak here, so data vendors find a receptive audience.

Pitch to session

What a precision oncology conference London buyer will ask you

Match your product to the buyer, the question they will open with, and the London 2027 sessions where that question is already on the table.

Your product	Likely buyer	Their first question	Sessions across both streams
NGS / CGP testing	Translational and CDx leads	Can your panel support patient selection and, later, a diagnostic claim?	Stream 2: Companion Diagnostics and the Role of Diagnostics in Precision Medicine (Roche); Keynote: Emerging Predictive & Prognostic Biomarkers in IO
RWE and health data	Biomarker strategy and medical affairs	Can your data show biomarker prevalence and outcomes in a real population?	Stream 2: Real-World Evidence Integration into Biomarker Strategy; Companion Diagnostics Commercialisation & Reimbursement Strategy
AI precision oncology	Digital, data science and pathology teams	What does your model add beyond existing biomarkers, and how was it validated?	Stream 1: AI protein design work and our various other digital initiatives (Merck KGaA); Stream 2: Digital Pathology & Spatial Transcriptomics in Oncology
Genomic data and trial-design platforms	Clinical development	Can you help enrich trials and manage risk by biomarker?	Stream 1: Clinical Trial Design in Immunotherapy: Adaptive & Biomarker-Driven Models; Precision Safety Management & Risk Mitigation in IO

The 2027 Key Highlights also name “Reimbursement and commercialisation strategies for precision oncology” and “AI-driven drug discovery and translational acceleration”, so commercial and data topics run through the programme rather than sitting in one session.

UK context

The NHS genomic context behind a genomic medicine conference London audience

England’s NHS Genomic Medicine Service, with its National Genomic Test Directory and network of NHS Genomic Laboratory Hubs, shapes how UK-based teams think about routine testing. Your buyers plan their UK trials and launches with it in mind.

For CGP providers

Pharma teams want to know how their biomarker will be tested in practice. Being able to explain how your test relates to NHS routine testing is a strong opening.

For RWE companies

UK health data is a known asset to the industry. Buyers will ask about linkage, access routes and how quickly you can deliver an analysis.

For HTA and access

The 2027 speaker panel includes a NICE clinical expert, Mohammad Alhadj Ali, and the agenda covers CDx reimbursement. Evidence for appraisal is part of the conversation.

This is still mainly an industry audience: 55–60% biotech and pharma, with 60% of delegates from the UK & Ireland and 40% from the rest of Europe. If you are comparing it with a broad personalised medicine conference London hosts across all disease areas, the difference is focus. Every buyer here works in oncology, which makes it a sharper precision medicine conference UK vendors can build a pipeline from.

Packages

Which package fits a genomics or data vendor

Because precision oncology buyers sit in both streams, the package question is whether you can reach both, or should pick the stream where your main buyer sits.

Best fit

Headline

The only package that puts you on stage in both streams: a welcome speech and a 30-minute keynote slot on Day 1 morning, before the streams split into their programmes. It suits a platform that serves translational, clinical and data teams at once.

Exclusive to one company; “Powered by” branding
Welcome speech and 30-minute Day 1 keynote, both streams
15 pre-scheduled 1:1 meetings
20 x 12 ft exhibition space; 10 + 10 passes
Email campaign to the full pre-qualified database

Platinum

Pick the stream where your buyer sits: Stream 2 for CGP and diagnostics, Stream 1 for trial-design, safety and AI discovery tools.

30-minute Day 1 talk plus Q&A
10 pre-scheduled 1:1 meetings
10 x 6 ft booth; 8 + 8 passes
Email to attendees; attendee list a week before

Drinks reception sponsor

The end-of-Day-1 reception is where both streams mix. A branding option for data vendors whose sale starts with an informal conversation.

Exclusive to one company
5-minute welcome speech
Logo on all invitations; banners in the networking area
2 passes

Compare all tiers on the London sponsorship opportunities page, and use the ROI calculator below to test the numbers.

Two-day plan

Covering both streams at the precision medicine conference UK 2027 edition

A sample plan for a team of four, built on the published London 2027 agenda. Pre-booked 1:1 meetings fit around the sessions.

Day 1 morning: split the teamOne person in Stream 2 for Clinical Utility of Biomarkers and the Roche session on diagnostics in precision medicine; one in Stream 1 for the Merck KGaA digital initiatives talk.
Day 1 afternoon: panelsStream 2 panel on Regulatory Harmonisation for Biomarker Qualification runs at the same time as the Stream 1 panel on Scaling Immunotherapies from Discovery to Commercialisation.
Day 1 late afternoon: precision sessionsThe Future of Biomarker-Driven Oncology and Digital Pathology & Spatial Transcriptomics in Oncology in Stream 2; Clinical Trial Design in Immunotherapy: Adaptive & Biomarker-Driven Models in Stream 1.
Day 1 evening: drinks receptionBoth streams in one room. Follow up with the people you heard ask questions.
Day 2 morning: evidenceReal-World Evidence Integration into Biomarker Strategy, then Companion Diagnostics Commercialisation & Reimbursement Strategy before lunch.
Day 2 afternoon: approval and partneringGlobal CDx Approval Pathways – EMA, FDA & MHRA Perspectives and Companion Diagnostics Co-development Strategies in Stream 2; Translational Research: Bridging Academia & Industry in Stream 1.

For a series-wide view of precision oncology sponsorship, see the precision medicine conference 2027 page. If your test is heading for a CDx claim, read the companion diagnostics conference London page; if you sell into immunotherapy programmes, see the cancer immunotherapy conference London page. Our advanced therapies biomarker outlook covers where biomarker demand is heading.

Tell us what your platform does and which teams you sell to, and we will suggest a stream and package.

Request the prospectus

Sponsorship ROI calculator

What could London 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages

Exclusive 1:1 meeting packages

2. Your numbers

Average first-year deal value

Year-one value of a new pharma or biotech customer

Extra conversations at the event

Booth visits, networking and questions after your talk

Become a real opportunity

Share of conversations worth a proposal

Opportunities you usually win

Your typical close rate

Your total event budget

Sponsorship plus travel and team costs

Estimated return

expected first-year revenue for every £1 of your event budget

Pre-scheduled 1:1 meetings

Qualified conversations

New opportunities

Cost per conversation

Pipeline created

Expected revenue won

Get pricing and the prospectus for this package Or talk to our team about a custom package

Estimates only, based on the numbers you enter. Meetings and inclusions from the London 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

Project Manager

PromoCell GmbH · Sponsor, London 2026

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

BD Manager Europe

Secretech · Sponsor, London 2026

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

Research Account Manager

Miltenyi Biotec · Sponsor, London 2026

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

Senior Business Development Director Europe

Rouken Bio · Sponsor, London 2026

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

Epigenomics Applications Specialist

Hologic Diagenode · Sponsor, London 2026

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Biopharma Business Development Manager EMEA

Hologic Diagenode · Sponsor, London 2026

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

Business Development Executive

HistologiX · Sponsor, London 2026

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Product Specialist

HAWK Biosystems · Sponsor, London 2026

Get the prospectus

Frequently asked questions

Which stream should an NGS or CGP provider choose?

Most CGP and NGS providers choose Stream 2, Biomarkers & Companion Diagnostics, which covers clinical utility of biomarkers, CDx and digital pathology. Stream 1 suits platforms used in biomarker-driven trial design and safety. The Headline package is the only one with a Day 1 keynote across both streams.

Are clinicians and NHS-related delegates in the audience?

Clinicians make up 5–10% of delegates and government, regulatory and industry bodies about 5%. The 2027 speaker panel includes a NICE clinical expert. Most delegates (55–60%) come from biotech and pharma, so treat this as an industry audience with clinical input rather than an NHS event.

Does the agenda cover real-world evidence and reimbursement?

Yes. Day 2 of Stream 2 includes Real-World Evidence Integration into Biomarker Strategy and Companion Diagnostics Commercialisation & Reimbursement Strategy, and the 2027 highlights include reimbursement and commercialisation strategies for precision oncology.

What does the Headline package include?

Headline is exclusive to one company. It includes 15 pre-scheduled 1:1 meetings, 10 delegate and 10 client passes, a welcome speech plus a 30-minute Day 1 keynote slot across both streams, a 20 x 12 ft exhibition space, an email campaign to the full pre-qualified database and 'Powered by' branding.

Can we bring clients or partners?

Yes. Sponsor tiers include client passes alongside team passes: 10 + 10 with Headline, 8 + 8 with Platinum, 6 + 6 with Gold, 4 + 4 with Silver and 2 + 2 with Exhibitor. Each branding package includes 2 passes.

Precision Medicine Conference London for Genomics & Data Vendors

Get the prospectus and package availability